| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.52▼ | 2.52▼ | 2.52▼ | 2.52▼ | 2.63▼ |
| MA10 | 2.53▼ | 2.52▼ | 2.53▼ | 2.53▼ | 3.46▼ |
| MA20 | 2.52▼ | 2.53▼ | 2.53▼ | 2.63▼ | 4.02▼ |
| MA50 | 2.53▼ | 2.52▼ | 2.54▼ | 3.53▼ | 4.61▼ |
| MA100 | 2.53▼ | 2.55▼ | 2.57▼ | 4.12▼ | N/A |
| MA200 | 2.53▼ | 2.59▼ | 2.99▼ | 4.46▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.001▲ | 0.001▲ | 0.050▲ | -0.166▼ |
| RSI | 44.017▼ | 45.821▼ | 46.644▼ | 36.574▼ | 34.797▼ |
| STOCH | 41.667 | 45.887 | 49.055 | 34.450 | 7.474▼ |
| WILL %R | -90.000▼ | -81.818▼ | -72.000 | -74.675 | -94.879▼ |
| CCI | -48.773 | -8.754 | -8.791 | -63.720 | -114.560▼ |
| MA | $TELO Price Crossed Below MA(7) | Set Alert |
|
Saturday, April 12, 2025 05:17 PM
Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported ...
|
|
Friday, April 11, 2025 07:55 AM
Telomir Pharmaceuticals (NASDAQ:TELO) on Tuesday announced results from recent preclinical studies demonstrating the ability of Telomir-1 to fully reverse oxidative stress in human cell lines.
|
|
Tuesday, April 08, 2025 05:00 PM
Telomir Pharmaceuticals (NASDAQ:TELO – Get Free Report) is one of 1,072 public companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors?
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 2.56 | 2.61 | 2.45 | 2.51 | 138,260 |
| 30/04/25 | 2.56 | 2.56 | 2.43 | 2.55 | 131,800 |
| 29/04/25 | 2.505 | 2.57 | 2.42 | 2.52 | 158,896 |
| 28/04/25 | 2.54 | 2.64 | 2.354 | 2.49 | 248,800 |
| 25/04/25 | 2.52 | 2.60 | 2.52 | 2.55 | 57,665 |
| 24/04/25 | 2.55 | 2.70 | 2.485 | 2.56 | 127,740 |
| 23/04/25 | 2.72 | 2.79 | 2.49 | 2.54 | 137,500 |
| 22/04/25 | 2.59 | 2.65 | 2.52 | 2.60 | 72,100 |
| 21/04/25 | 2.47 | 2.74 | 2.46 | 2.54 | 143,400 |
| 17/04/25 | 2.47 | 2.65 | 2.38 | 2.48 | 56,100 |
|
|
||||
|
|
||||
|
|